Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Candesartan Proven Effective for Migraine Prevention
October 2025
Trial shows candesartan cuts migraine days and is well tolerated. Read more to learn about this promising prevention therapy.
Read more
10 Jun 2016
New Janssen Phase 3 Data in Patients with Moderately to Severely Active Rheumatoid Arthritis Shows Sirukumab Significantly Inhibited Radiographic Progression and Improves Signs and Symptoms of Disease
London, United Kingdom, 8 June, 2016 – Janssen Research & Development, LLC (Janssen) announced today results from a pivotal Phase 3 study evaluating…
9 May 2016
‘Leaky’ Vessels Answer to Unresponsive Cancer
PROMISING research, which has implications for the development of treatments for medulloblastoma, the most common brain tumour in children, has emerged…
9 May 2016
Brain Rewiring After Stroke May be Answer to Therapy
RECOVERY following a stroke can be difficult, but a new study gives an insight into potential recovery markers and new treatment options.
4 May 2016
Otometrics and Maastrict University Drive Greater Understanding of the Paradigm Shift in Vestibular Assessment with New Master Class
Taastrup, Denmark | April 7, 2016 – GN Otometrics, the leading global manufacturer of hearing and balance instrumentation will host a two-day vestibular…
29 Apr 2016
Neurological Expertise Crucial to Deal with Devastating Zika Consequences
London, 28 April 2016 — “The Zika virus is more and more showing its ugly face, and the international community increasingly realises the dimensions of…
27 Apr 2016
MedDay appoints Catherine Moukheibir as Chairman of its Board of Directors
Paris, France, 27 April 2016 – MedDay, a biotechnology company focused on the treatment of nervous system disorders, today announces the appointment of…
24 Feb 2016
Artificial Intelligence May Help Override Fearful Memories
SCIENTISTS have created a procedure that can remove specific fearful memories from the brain, which could be used as a new therapy for treating…
15 Feb 2016
New Drug has Potential for Neuron Preservation in Parkinson’s Disease
IMPROVED treatment for Parkinson’s disease could be on the horizon following successful trials of a new drug that can treat the condition by changing…
Loading posts...
« Previous
1
…
43
44
45
46
47
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View